Since the trial started over 4 years ago, presumably many of those dogs by now have reached the heart failure stage of MVD, and their reports should be piling up in the in-boxes of the study's leaders, including Dr
Gilden, who also serves as a medical reviewer for Everyday Health
Given the rapid evolution of this field, future breakthroughs, including new drug approvals and expanded indications, necessitate systematic updates of the literature
Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention
These results support the findings of two similar meta-analyses that looked at the effect of baseline metformin use in the HARMONY-OUTCOMES and LEADER trials, and the HARMONY-OUTCOMES, REWIND, EXSCEL and LEADER trials, respectively [14, 15], as well as individual analyses investigating the impact of baseline metformin use on CV risk in patients treated with different GLP-1RAs reported previously [10,11,12]
10.1007/s10157-019-01829-z [DOI] [PubMed] [Google Scholar] 408.Stack, A